三友医疗
(688085)
| 流通市值：47.03亿 | | | 总市值：52.60亿 |
| 流通股本：2.48亿 | | | 总股本：2.78亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 339,958,900.17 | 403,089,371.13 | 439,770,777.33 | 524,378,741.97 |
| 应收票据及应收账款 | 80,792,333.37 | 73,140,409.12 | 71,104,971.01 | 65,134,982.38 |
| 应收账款 | 80,792,333.37 | 73,140,409.12 | 71,104,971.01 | 65,134,982.38 |
| 预付款项 | 10,403,494.55 | 9,202,621.19 | 17,524,181.82 | 16,402,301.63 |
| 其他应收款合计 | 3,815,204.75 | 3,827,943.13 | 2,582,541.52 | 2,319,915.83 |
| 存货 | 263,021,554.28 | 246,112,828.09 | 229,095,877.14 | 217,493,560.04 |
| 一年内到期的非流动资产 | 97,101,547.95 | 97,101,547.95 | - | - |
| 其他流动资产 | 147,744,811.6 | 150,927,842.41 | 6,930,779.63 | 17,057,378.33 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,028,058,169.96 | 1,033,632,289.05 | 886,291,670.89 | 902,925,208.95 |
| 非流动资产: | | | | |
| 长期股权投资 | 12,255,487.14 | 13,303,719.33 | 13,843,145.75 | 14,844,734.81 |
| 其他非流动金融资产 | 382,581,416.92 | 381,581,416.95 | 377,388,565.43 | 378,514,006.77 |
| 固定资产 | 323,256,477.33 | 325,360,252.96 | 328,696,802.14 | 333,022,462.6 |
| 在建工程 | 7,407,612.32 | 5,456,724.67 | 5,894,792.65 | 6,038,597.08 |
| 使用权资产 | 14,316,557.27 | 15,764,850.41 | 6,913,907.11 | 8,028,761.74 |
| 无形资产 | 83,187,614.15 | 88,709,341.5 | 101,482,987.97 | 103,868,577.79 |
| 商誉 | 345,867,050.16 | 345,867,050.16 | 344,476,576.84 | 344,476,576.84 |
| 长期待摊费用 | 30,285,138.07 | 32,486,743.76 | 32,915,002.78 | 38,598,470.04 |
| 递延所得税资产 | 3,234,713.26 | 3,804,054.48 | 21,743,777.86 | 22,296,876.4 |
| 其他非流动资产 | 61,446,028.93 | 60,693,807.56 | 167,273,124.65 | 136,318,951.7 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,263,838,095.55 | 1,273,027,961.78 | 1,400,628,683.18 | 1,386,008,015.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,291,896,265.51 | 2,306,660,250.83 | 2,286,920,354.07 | 2,288,933,224.72 |
| 流动负债: | | | | |
| 短期借款 | 15,253,325.22 | 15,253,325.22 | - | 10,000,000 |
| 应付票据及应付账款 | 85,946,005 | 86,680,917.98 | 89,220,337.07 | 93,690,405.97 |
| 应付账款 | 85,946,005 | 86,680,917.98 | 89,220,337.07 | 93,690,405.97 |
| 合同负债 | 3,970,538.27 | 6,227,339.68 | 2,588,879.09 | 3,125,889.78 |
| 应付职工薪酬 | 18,406,379.78 | 29,334,857.24 | 24,164,853.3 | 22,693,901.52 |
| 应交税费 | 6,858,102.33 | 9,227,039.68 | 8,412,749.61 | 5,511,945.49 |
| 其他应付款合计 | 54,271,656.26 | 54,759,751.29 | 58,375,224.51 | 53,162,064.02 |
| 一年内到期的非流动负债 | 14,224,086.2 | 15,262,479.1 | 17,963,437.12 | 19,269,115.42 |
| 其他流动负债 | 7,864,624.89 | 8,091,558.62 | 400,258.77 | 423,464.34 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 206,794,717.95 | 224,837,268.81 | 201,125,739.47 | 207,876,786.54 |
| 非流动负债: | | | | |
| 长期借款 | 5,673,363.56 | 8,382,102.08 | 7,717,554.94 | 10,710,539.43 |
| 租赁负债 | 7,468,886.14 | 7,998,633.29 | 2,365,151.52 | 2,555,695.68 |
| 长期应付职工薪酬 | 1,635,011 | 1,635,011 | - | - |
| 预计负债 | 1,282,632.09 | 1,041,162.79 | 436,238.09 | 332,612.64 |
| 递延收益 | 6,923,792.9 | 7,118,233.82 | 6,499,478.14 | 6,295,036.33 |
| 递延所得税负债 | 6,954,493.38 | 6,898,945.31 | 21,841,499.21 | 21,752,211.54 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 29,938,179.07 | 33,074,088.29 | 38,859,921.9 | 41,646,095.62 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 236,732,897.02 | 257,911,357.1 | 239,985,661.37 | 249,522,882.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 277,885,415 | 248,453,535 | 248,453,535 | 248,453,535 |
| 资本公积 | 1,091,845,022.37 | 1,016,201,604.67 | 1,015,639,296.11 | 1,015,810,636.93 |
| 其他综合收益 | -583,381.21 | -520,571.35 | 1,375,601.57 | 712,766.01 |
| 盈余公积 | 75,480,757.35 | 75,480,757.35 | 74,110,829.56 | 74,110,829.56 |
| 未分配利润 | 585,063,902.96 | 572,182,118.62 | 570,654,011.27 | 563,759,565.74 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,029,691,716.47 | 1,911,797,444.29 | 1,910,233,273.51 | 1,902,847,333.24 |
| 少数股东权益 | 25,471,652.02 | 136,951,449.44 | 136,701,419.19 | 136,563,009.32 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,055,163,368.49 | 2,048,748,893.73 | 2,046,934,692.7 | 2,039,410,342.56 |
| 负债和股东权益合计 | 2,291,896,265.51 | 2,306,660,250.83 | 2,286,920,354.07 | 2,288,933,224.72 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-29 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |